Stockreport

RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF through 2035 and adds to opaganib's strong global intellectual property portfolio across multiple indications U.S. Army studies suggest that opaganib may be the first [Read more]